Mariam Hull

Dr. Mariam Hull

Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
PDF file
MHMariam Hull
Mariam Hull
MPMered Parnes
Mered Parnes

1 October 2021 in Neurology Clinical Practice
Verified
Journal Article
Closed access
PDF file
MHMariam Hull
Mariam Hull
MPMered Parnes
Mered Parnes
Joseph JankovicJoseph Jankovic
Joseph Jankovic
Background and Objectives Functional (psychogenic) movement disorders (FMDs) are conditions in which affected patients develop abnormal movements that are incongruous with known, organic, movement disorders, often associated with psychological stressors. Methods In this case series, electronic medical records of all patients who presented to our adult and pediatric tertiary care movement disorders clinics between March 1 and October 30, 2020, and during the same period in 2019 were reviewed. All patients diagnosed with functional (psychogenic) movement disorder were included if they satisfied diagnostic criteria. Results Among 550 new patients referred for evaluation at our tertiary care movement disorders centers, 45 (8.2%) received a diagnosis of FMD; 75.6% were female, in comparison to the prior year during which time 665 new patients were evaluated and 5.1% were diagnosed with FMD. This represents a 60.1% increase (90.1% in pediatric cohort, 50.9% in adult cohort) in new patients diagnosed with FMD during the COVID-19 pandemic. Conclusions Within our patient population, there has been increased incidence of FMDs in the setting of the COVID-19 pandemic, possibly reflecting increased psychological and other stressors during this period.

20 June 2022 in Movement Disorders
Verified
Journal Article
Open access
TWThomas Wirth
Thomas Wirth
GGGiacomo Garone
Giacomo Garone
MKManju A Kurian
Manju A Kurian
APAmélie Piton
Amélie Piton
FMFrancisca Millan
Francisca Millan
MAMathieu Anheim
Mathieu Anheim
Background: Most reported patients carrying GNAO1 mutations showed a severe phenotype characterized by early‐onset epileptic encephalopathy and/or chorea.Objective: The aim was to characterize the clinical and genetic features of patients with mild GNAO1‐related phenotype with prominent movement disorders.Methods: We included patients diagnosed with GNAO1‐related movement disorders of delayed onset (>2 years). Patients experiencing either severe or profound intellectual disability or early‐onset epileptic encephalopathy were excluded.Results: Twenty‐four patients and 1 asymptomatic subject were included. All patients showed dystonia as prominent movement disorder. Dystonia was focal in 1, segmental in 6, multifocal in 4, and generalized in 13. Six patients showed adolescence or adulthood‐onset dystonia. Seven patients presented with parkinsonism and 3 with myoclonus. Dysarthria was observed in 19 patients. Mild and moderate ID were present in 10 and 2 patients, respectively.Conclusion: We highlighted a mild GNAO1‐related phenotype, including adolescent‐onset dystonia, broadening the clinical spectrum of this condition. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

12 February 2021 in Toxins
Verified
Journal Article
Open access
PDF file
MHMariam Hull
Mariam Hull
MPMered Parnes
Mered Parnes
Joseph JankovicJoseph Jankovic
Joseph Jankovic
Opisthotonus refers to abnormal axial extension and arching of the trunk produced by excessive contractions of the paraspinal muscles. In childhood, the abnormal posture is most often related to dystonia in the setting of hypoxic injury or a number of other acquired and genetic etiologies. The condition is often painful, interferes with ambulation and quality of life, and is challenging to treat. Therapeutic options include oral benzodiazepines, oral and intrathecal baclofen, botulinum neurotoxin injections, and deep brain stimulation. Management of opisthotonus within the pediatric population has not been systematically reviewed. Here, we describe a series of seven children who presented to our institution with opisthotonus in whom symptom relief was achieved following administration of botulinum neurotoxin injections.

17 August 2020 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
MHMariam Hull
Mariam Hull
MPMered Parnes
Mered Parnes
Geniospasm is a rare genetic disorder characterized by paroxysmal rhythmic or irregular movements of the chin and lower lip due to repetitive contractions of the mentalis muscle. Pathophysiology is poorly understood, and optimal treatment has not been established. Geniospasm was characterized in a series of patients after evaluation in our clinics, and a comprehensive review of all cases in the medical literature was performed. We evaluated four patients (1 female) in four families with geniospasm, aged 4 months to 9 years. Bothersome symptoms were present in one patient, who was treated with regular injections of onabotulinumtoxinA, with complete resolution of symptoms and no adverse effects. 9 patients in the literature have had similar outcomes. Limited data exist with regard to the effective treatment of geniospasm. Several treatments have been used historically, with variable outcomes. Our results, together with those of prior reported cases, demonstrate benefit of the use of botulinum toxin injections for management of this condition.

1 December 2021 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
MHMariam Hull
Mariam Hull
LELisa Emrick
Lisa Emrick
RSRoa Sadat
Roa Sadat
MPMered Parnes
Mered Parnes